Low-density lipoprotein particle size in type 2 diabetic patients and age matched controls
- PMID: 8060094
- DOI: 10.1177/000456329403100207
Low-density lipoprotein particle size in type 2 diabetic patients and age matched controls
Abstract
Non-enzymatic glycation of low-density lipoprotein (LDL), and the predominance of small dense LDL particles may together contribute to the increased risk of atherosclerosis in diabetes. We aimed to establish whether the size of LDL particles is related to plasma triglyceride concentration, and to the extent of LDL glycation in type 2 diabetic patients. Sixteen men with type 2 diabetes and 16 age matched non-diabetic controls were studied. LDL size was measured by rapid density gradient ultracentrifugation, and LDL glycation by affinity chromatography. Modal LDL density correlated with plasma triglyceride concentrations in both diabetic and control groups (r = 0.86, P < 0.0001, and r = 0.76, P < 0.0008, respectively). There was no significant difference in these variables between the groups. LDL modal density showed no correlation with HbA1, serum fructosamine or plasma glucose in either group. In the diabetic group the degree of LDL glycation correlated with serum fructosamine (r = 0.74, P < 0.001), HbA1 (r = 0.65, P < 0.008), and with plasma glucose (r = 0.64, P < 0.008). Our results suggest that, in well controlled type 2 diabetic patients LDL size is independent of short-term glycaemic control but can be predicted by plasma triglyceride concentrations.
Similar articles
-
High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy.Atherosclerosis. 1996 Jun;123(1-2):57-72. doi: 10.1016/0021-9150(95)05772-2. Atherosclerosis. 1996. PMID: 8782837
-
Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.Metabolism. 2003 Jan;52(1):116-21. doi: 10.1053/meta.2003.50018. Metabolism. 2003. PMID: 12524671 Clinical Trial.
-
Glycation of lipoproteins and accelerated atherosclerosis in non-insulin-dependent diabetes mellitus.Int J Clin Lab Res. 1995;25(3):157-61. doi: 10.1007/BF02592559. Int J Clin Lab Res. 1995. PMID: 8562980
-
Clinical significance of the physicochemical properties of LDL in type 2 diabetes.Diabetologia. 2005 May;48(5):808-16. doi: 10.1007/s00125-005-1736-0. Epub 2005 Apr 14. Diabetologia. 2005. PMID: 15830178 Review.
-
The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus.Metabolites. 2021 Nov 28;11(12):807. doi: 10.3390/metabo11120807. Metabolites. 2021. PMID: 34940565 Free PMC article. Review.
Cited by
-
Effect of non-enzymatic glycation on esterase activities of hemoglobin and myoglobin.Mol Cell Biochem. 2007 Jul;301(1-2):251-7. doi: 10.1007/s11010-007-9418-5. Epub 2007 Feb 14. Mol Cell Biochem. 2007. PMID: 17549609
-
Diabetic dyslipidaemia: current treatment recommendations.Drugs. 2000 May;59(5):1101-11. doi: 10.2165/00003495-200059050-00006. Drugs. 2000. PMID: 10852642 Review.
-
Effect of glycation of hemoglobin on its interaction with trifluoperazine.Protein J. 2006 Apr;25(3):202-11. doi: 10.1007/s10930-006-9003-x. Protein J. 2006. PMID: 16755386
-
The clinical biochemistry of obesity.Clin Biochem Rev. 2004 Aug;25(3):165-81. Clin Biochem Rev. 2004. PMID: 18458706 Free PMC article.
-
Non-enzymatic glycation induces structural modifications of myoglobin.Mol Cell Biochem. 2010 May;338(1-2):105-14. doi: 10.1007/s11010-009-0343-7. Epub 2009 Nov 29. Mol Cell Biochem. 2010. PMID: 20091095
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous